Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure
- 30 October 2004
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 148 (5) , 920-926
- https://doi.org/10.1016/j.ahj.2004.05.027
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failurePublished by Elsevier ,2010
- Prospective Study of Heart Rate Variability and Mortality in Chronic Heart FailureCirculation, 1998
- Heart Rate Variability in Idiopathic Dilated Cardiomyopathy: Characteristics and Prognostic ValueJournal of the American College of Cardiology, 1997
- Effects of bisoprolol on heart rate variability in heart failureThe American Journal of Cardiology, 1996
- Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.Circulation, 1994
- Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.Circulation, 1993
- Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failureJournal of the American College of Cardiology, 1993
- Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.Circulation, 1993
- Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: Demonstration in human subjects and verification in a paced canine model of ventricular failureJournal of the American College of Cardiology, 1991
- Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.Journal of Clinical Investigation, 1991